Marginal-zone B cells

Nature Reviews Immunology

Volumn 2, Issue 5, 2002, Pages 323-335

  Martin, Flavius ^a,b   Kearney, John F ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

ANIMAL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; IMMUNOLOGY; MOUSE; MOUSE MUTANT; RAT; REVIEW; SIGNAL TRANSDUCTION; SPLEEN; STEM CELL; TRANSGENIC MOUSE; ANIMAL CELL; ANIMAL MODEL; CELL FUNCTION; CELL LINE; CELL MATURATION; GENOMICS; IMMUNE SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; HUMANS; LIGANDS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; RATS; SIGNAL TRANSDUCTION; SPLEEN; STEM CELLS;

EID: 0036580887     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri799     Document Type: Review

References (132)

1. Goodnow, C. C. Balancing immunity autoimmunity and self-tolerance. Ann. NY Acad. Sci. 815, 55-66 (1997).
2. Rolink, A. & Melchers, F. B-cell development in the mouse. Immunol. Lett. 54, 157-161 (1996).
3. Osmond, D. G., Rolink, A. & Melchers, F. Murine B lymphopoiesis: towards a unified model. Immunol. Today 19, 65-68 (1998).
4. Kantor, A. B., Stall, A. M., Adams, S. & Herzenberg, L. A. Adoptive transfer of murine B-cell lineages. Ann. NY Acad. Sci. 651, 168-169 (1992).
5. Stall, A. M., Wells, S. M. & Lam, K. P. B-1 cells: unique origins and functions. Semin. Immunol. 8, 45-59 (1996).
6. - B-lymphocyte subsets. Eur. J. Immunol. 12, 564-569 (1982).
7. Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H. & Kearney, J. F. Marginal-zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27, 2366-2374 (1997).
8. Bendalac, A., Bonneville, M. & Kearney, J. F. Autoreactivity by design: innate B and T lymphocytes. Nature Rev. Immunol. 1, 177-186 (2001).
9. high splenic B cells enriched in the marginal zone: distinct phenotypes and functions. Curr. Top. Microbiol. Immunol. 246, 45-50 (1999).
10. Martin, F. & Kearney J. F. B-cell subsets and the mature preimmune repertoire. Marginal-zone and B1 B cells as part of a 'natural immune memory'. Immunol. Rev. 175, 70-79 (2000).
11. Fagarasan, S., Watanabe, N. & Honio, T. Generation, expansion, migration and activation of mouse B1 cells. Immunol. Rev. 176, 205-215 (2000).
12. MacLennan, I. C., Bazin, H., Chassoux, D., Gray, D. & Lortan, J. Comparative analysis of the development of B cells in marginal zones and follicles. Adv. Exp. Med. Biol. 188, 139-144 (1985).
13. Mond, J. J., Vos, Q., Lees, A. & Snapper, C. M. T-cell-independent antigens. Curr. Opin. Immunol. 7, 349-354 (1995).
14. Ridge, J. P., Fuchs, E. J. & Matzinger, P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723-1726 (1996).
15. Hardy, R. R. & Hayakawa, K. A developmental switch in B lymphopoiesis. Proc. Natl Acad. Sci. USA 88, 11550-11554 (1991).
16. Hamilton, A. M., Lehuen, A. & Kearney, J. F. Immunofluorescence analysis of B-1 cell ontogeny in the mouse. Int. Immunol. 6, 355-361 (1994).
17. Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682 (1988).
18. Martin, F., Chen, X. & Kearney, J. F. Development of VH81X transgene-bearing B cells in fetus and adult: sites for expansion and deletion in conventional and CD5/B1 cells. Int. Immunol. 9, 493-505 (1997).
19. Martin, F. & Kearney, J. F. Positive selection from newly formed to marginal-zone B cells depends on the rate of clonal production, CD19 and btk. Immunity 12, 39-49 (2000). This study shows positive selection of specific clones into the MZ B-cell compartment.
20. Erikson, J. et al. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349, 331-334 (1991).
21. Wellmann, U., Werner, A. & Winkler, T. H. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur. J. Immunol. 31, 2800-2810 (2001).
22. Kenny, J. J. et al. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J. Immunol. 164, 4111-4119 (2000).
23. Weaver, D. et al. Altered repertoire of endogenous immunoglobulin gene expression in transgenic mice containing a rearranged μ heavy-chain gene. Cell 45, 247-259 (1986).
24. Cascalho, M., Wong, J. & Wabl, M. VH gene replacement in hyperselected B cells of the quasimonoclonal mouse. J. Immunol. 159, 5795-5801 (1997).
25. Qin, X. F. et al. Secondary V(D)J recombination in B-1 cells. Nature 397, 355-359 (1999).
26. -/- mice. J. Exp. Med. 194, 1141-1150 (2001).
27. Hao, Z. & Rajewsky, K. Homeostasis of peripheral B cells in the absence of B-cell influx from the bone marrow. J. Exp. Med. 194, 1151-1164 (2001).
28. Martin, F., Won, W. J. & Kearney, J. F. Generation of the germline peripheral B-cell repertoire: VH81X-λ B cells are unable to complete all developmental programs. J. Immunol. 160, 3748-3758 (1998).
29. Cariappa, A. et al. The follicular versus marginal-zone B-lymphocyte cell-fate decision is regulated by Aiolos, Btk and CD21. Immunity 14, 603-615 (2001).
30. Cooper, M. D., Cain, W. A., Van Alten, P. J. & Good, R. A. Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int. Arch. Allergy Appl. Immunol. 35, 242-252 (1969).
31. Kincade, P. W., Self, K. S. & Cooper, M. D. Survival and function of bursa-derived cells in bursectomized chickens. Cell. Immunol. 8, 93-102 (1973).
32. Sprent, J., Schaefer, M., Hurd, M., Surh, C. D. & Ron, Y. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J. Exp. Med. 174, 717-728 (1991).
33. Agenes, F. & Freitas, A. A. Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B-cell population. J. Exp. Med. 189, 319-330 (1999).
34. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162, 7198-7207 (1999).
35. Hayakawa, K. et al. Positive selection of natural autoreactive B cells. Science 285, 113-116 (1999). The first demonstration of a defined self antigen (Thy1-associated epitope) that has a role in positive selection and/or maintenance of the B1 repertoire.
36. Radic, M. Z., Erikson, J., Litwin, S. & Weigert, M. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177, 1165-1173 (1993).
37. Li, H., Jiang, Y., Prak, E. L., Radic, M. & Weigert, M. Editors and editing of anti-DNA receptors. Immunity 15, 947-957 (2001).
38. Chen, X., Martin, F., Forbush, K. A., Pedmutter, R. M. & Kearney, J. F. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9, 27-41 (1997).
39. Li, Y., Li, H. & Weigert, M. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195, 181-188 (2002).
40. Okamoto, M. et al. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175, 71-79 (1992).
41. Torres, R. M., Flaswinkel, H., Reth, M. & Rajewsky, K. Aberrant B-cell development and immune response in mice with a compromised BCR complex. Science 272, 1804-1808 (1996).
42. Kraus, M. et al. Interference with immunoglobulin (Ig)α immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B-cell development, depending on the availability of an Igβ cytoplasmic tail. J. Exp. Med. 194, 455-469 (2001).
43. high B cells: a population of mixed origin. Eur. J. Immunol. 29, 3285-3294 (1999).
44. Otipoby, K. L. et al. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384, 634-637 (1996).
45. Sato, S. et al. CD22 is both a positive and negative regulator of B-lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5, 551-562 (1996).
46. O'Keefe, T. L., Williams, G. T., Batista, F. D. & Neuberger, M. S. Deficiency in CD22, a B-cell-specific inhibitory receptor, is sufficient to predispose to development of high-affinity autoantibodies. J. Exp. Med. 189, 1307-1313 (1999).
47. Cornall, R. J. et al. Polygenic autoimmune traits: Lyn, CD22 and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8, 497-508 (1998).
48. Cyster, J. G. et al. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381, 325-328 (1996).
49. Pan, C., Baumgarth, N. & Parnes, J. R. CD72-deficient mice reveal nonredundant roles of CD72 in B-cell development and activation. Immunity 11, 495-506 (1999).
50. Bikah, G., Carey J., Ciallella, J. R., Tarakhovsky, A. & Bondada, S. CD5-mediated negative regulation of antigen-receptor-induced growth signals in B-1 B cells. Science 274, 1906-1909 (1996).
51. Cyster, J. G. & Goodnow, C. C. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2, 13-24 (1995).
52. Schmidt, K. N., Hsu, C. W., Griffin, C. T., Goodnow, C. C. & Cyster, J. G. Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells. J. Exp. Med. 187, 929-937 (1998).
53. Tarakhovsky, A. et al. Defective antigen-receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374, 467-470 (1995).
54. Fruman, D. A. et al. Impaired B-cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283, 393-397 (1999).
55. Suzuki, H. et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283, 390-392 (1999).
56. Leitges, M. et al. Immunodeficiency in protein-kinase-Cβ-deficient mice. Science 273, 788-791 (1996).
57. Wang, J. H. et al. Aiolos regulates B-cell activation and maturation to effector state. Immunity 9, 543-553 (1998).
58. Hatzivassiliou, G. et al. IRTA1 and IRTA2 novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B-cell malignancy. Immunity 14, 277-289 (2001).
59. Davis, R. S., Wang, Y. H., Kubagawa, H. & Cooper, M. D. Identification of a family of Fc receptor homologs with preferential B-cell expression. Proc. Natl Acad. Sci. 98, 9772-9777 (2001).
60. Matsumoto, M. et al. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271, 1289-1291 (1996).
61. Matsumoto, M. et al. Distinct roles of lymphotoxin-α and the type I tumor-necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone-marrow-derived cells. J. Exp. Med. 186, 1997-2004 (1997).
62. Korner, H. et al. Recirculating and marginal-zone B-cell populations can be established and maintained independently of primary and secondary follicles. Immunol. Cell Biol. 79, 54-61 (2001).
63. Ngo, V. N. et al. Lymphotoxin α/β and tumor-necrosis factor are required for stromal-cell expression of homing chemokines in B- and T-cell areas of the spleen. J. Exp. Med. 189. 403-412 (1999).
64. Ansel, K. M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309-314 (2000). Using BLC-deficient mice, this study shows the positive effect of BLC on the lymphotoxin pathway that eventually amplifies B-cell migration; it separates B-cell follicles into two 'migratory' subunits.
65. Gross, J. A. et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999 (2000). Together with reference 68, this paper identifies the first two receptors in the BAFF pathway.
66. Xu, S. & Lam, K. P. B-cell maturation protein, which binds the tumor-necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell Biol. 21, 4067-4074 (2001).
67. Yan, M. et al. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nature Immunol. 1, 37-41 (2000).
68. Laabi, Y., Egle, A. & Strasser A. TNF cytokine family: more BAFF-ling complexities. Curr. Biol. 11, R1013-R1016 (2001).
69. Thompson, J. S. et al. BAFF-R, a newly identified TNF receptor that specifically interacts with SAFF. Science 293, 2106-2111 (2001). Together with reference 70, this study identifies a third, specific BAFF receptor that has an important impact on B-cell development.
70. Yan, M. et al. Identification of a novel receptor for B-lymphocyte stimulator that is mutated in a mouse strain with severe B-cell deficiency. Curr. Biol. 11, 1547-1552 (2001).
71. MacKay, F. et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697-1710 (1999).
72. Batten, M. et al. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192, 1453-1465 (2000).
73. Khare, S. D. et al. Severe B-cell hyperplasia and autoimmune disease in TALL-1-transgenic mice. Proc. Natl Acad. Sci. USA 97, 3370-3375 (2000).
74. Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114 (2001).
75. von Bulow, G. U., van Deursen, J. M. & Bram, R. J. Regulation of the T-independent humoral response by TACI. Immunity 14, 573-582 (2001). Together with reference 76, this paper implicates TACI as being crucial in T-cell-independent immune responses and as an attenuator of B-cell development and signalling.
76. Yan, M. et al. Activation and accumulation of B cells in TACI-deficient mice. Nature Immunol. 2, 638-643 (2001).
77. Nishimura, H., Minato, N., Nakano, T. & Honjo, T. Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B-cell responses. Int. Immunol. 10, 1563-1572 (1998).
78. Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM-motif-carrying immunoreceptor. Immunity 11, 141-151 (1999).
79. Yoshinaga, S. K. et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402, 827-832 (1999).
80. Yoshinaga, S. K. et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int. Immunol. 12, 1439-1447 (2000).
81. Gunn, M. D. et al. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391, 799-803 (1998).
82. Cyster J. G. et al. Chemokines and B-cell homing to follicles. Curr. Top. Microbiol. Immunol. 246, 87-92 (1999).
83. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J. V. Abscence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nature Immunol. 1, 31-36 (2000). The first glimpse of a defect that is related to a migratory pathway that affects marginal-zone (MZ) B-cell development; also indicates a role for the MZ in T-cell-independent immune responses.
84. Fukui, Y. et al. Haematopoietic cell-specific CDM-family protein DOCK2 is essential for lymphocyte migration. Nature 412, 826-831 (2001). DOCK2 is a crucial molecule for the chemokine-mediated activation of Rac and lymphocyte migration; DOCK2-deficient animals lack marginal-zone and B1 B cells, In addition to other defects.
85. Girkontaite, I. et al. Lsc is required for marginal-zone B cells, regulation of lymphocyte motility and immune responses. Nature Immunol. 2, 855-862 (2001). Lsc is another player in the lymphocyte-migration pathway, which, when missing, affects marginal-zone but not B1 B cells.
86. Doody, G. M. et al. Signal transduction through Vav-2 participates in humoral immune responses and B-cell maturation. Nature Immunol. 2, 542-547 (2001).
87. Tedford, K. et al. Compensation between Vav-1 and Vav-2 in B-cell development and antigen-receptor signaling. Nature Immunol. 2, 548-555 (2001).
88. Hla, T., Lee, M. J., Ancellin, N., Paik, J. H. & Kluk, M. J. Lysophospholipids - receptor revelations. Science 294, 1875-1878 (2001).
89. Le, L. Q. et al. Mice lacking the orphan G-protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14, 561-571 (2001).
90. Shi, C. S. & Kehrl, J. H. PYK2 links G(q)α and G(13)α signaling to NF-κB activation. J. Biol. Chem. 276, 31845-31850 (2001).
91. Moratz, C. et al. Regulator of G protein signaling 1 (RGS1) markedly impairs Giα signaling responses of B lymphocytes. J. Immunol. 164, 1829-1838 (2000).
92. Reif, K. & Cyster, J. G. RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J. Immunol. 164, 4720-4729 (2000).
93. Cariappa, A., Liou, H.-C. & Pillai, S. Nuclear factor κB is required for the development of marginal-zone B lymphocytes. J. Exp. Med. 192, 1175-1182 (2000).
94. Weih, D. S., Yilmaz, Z. B. & Weih, F. Essential role of RelB in germinal-center and marginal-zone formation and proper expression of homing chemokines. J. Immunol. 167, 1909-1919 (2001).
95. Grossmann, M. et al. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19, 6351-6360 (2000).
96. Fagarasan, S. et al. Alymphoplasia (aly)-type nuclear-factor-κ B-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J. Exp. Med. 191, 1477-1486 (2000).
97. Yin, L. et al. Defective lymphotoxin-β-receptor-induced NF-κB transcriptional activity in NIK-deficient mice. 291, 2162-2165 (2001).
98. Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495-1499 (2001).
99. Kaisho, T. et al. IκB kinase-α is essential for mature B-cell development and function. J. Exp. Med. 193, 417-426 (2001).
100. Hu, C. J. et al. PU. 1/Spi-B regulation of c-rel is essential for mature B-cell survival. Immunity 15, 545-555 (2001).
101. Cheng, P. et al. Nolch-1 regulates NF-κB activity in hemopoietic progenitor cells. J. Immunol. 167, 4458-4467 (2001).
102. Koch, U. et al. Subversion of the T/B lineage decision in the thymus by lunatic-fringe-mediated inhibition of Notch-1. Immunity 15, 225-236 (2001).
103. Wilson, A., MacDonald, H. R. & Radtke, F. Notch-1-deficient common lymphoid precursors adopt a B-cell fate in the thymus. J. Exp. Med. 194, 1003-1012 (2001).
104. Humbert, P. O. & Corcoran, L. M. Oct-2 gene disruption eliminates the peritoneal B-1 lymphocyte lineage and attenuates B-2 cell maturation and function. J. Immunol. 159, 5273-5284 (1997).
105. Martin, F. & Kearney, J. F. Selection in the mature B-cell repertoire. Curr. Top. Microbiol. Immunol. 252, 97-105 (2000).
106. Martin, F. & Kearney, J. F. Positive selection from newly formed to marginal-zone B cells depends on the rate of clonal production, CD19 and btk. Immunity 12, 39-49 (2000).
107. Shaw, P. X. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance and protective immunity. J. Clin. Invest. 105, 1731-1740 (2000).
108. Kearney, J. F. Immune recognition of OxLDL in atherosclerosis. J. Clin. Invest. 105, 1683-1685 (2000).
109. Gumperz, J. E. et al. Murine CD1d-restricted T-cell recognition of cellular lipids. Immunity 12, 211-221 (2000).
110. Martin, F., Oliver, A. M. & Kearney, J. F. Marginal-zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14, 617-629 (2001).
111. Qian, Y., Santiago, C., Borrero, M., Tedder, T. F. & Clarke, S. H. Lupus-specific antiribonucleoprotein B-cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B-cell receptor signaling thresholds. J. Immunol. 166, 2412-2419 (2001).
112. Grimaldi, C. M., Michael, D. J. & Diamond, B. Cutting edge: expansion and activation of a population of autoreactive marginal-zone B cells in a model of estrogen-induced lupus J. Immunol. 167, 1886-1890 (2001).
113. Wither, J. E., Roy, V. & Brennan, L. A. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice. Clin. Immunol. 94, 51-63 (2000).
114. Segundo, C, et al. Thyroid-infiltrating B lymphocytes in Graves' disease are related to marginal-zone and memory B-cell compartments. Thyroid 11, 525-530 (2001).
115. Groom, J. et al. Association of BAFF/BLyS overexpression and altered B-cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109, 59-68 (2002).
116. Korganow, A. S. et al. From systemic T-cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10, 451-461 (1999).
117. Hori, M. et al. Non-Hodgkin lymphomas of mice. Blood Cells Mol. Dis. 27, 217-222 (2001).
118. Morse, H. C. et al. Cells of the marginal zone - origins, function and neoplasia. Leuk. Res. 25, 169-178 (2001).
119. Kraal, G. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132, 31-74 (1992).
120. Pettersen, J. C. Borgen, D. F. & Graupner, K. C. A morphological and histochemical study of the primary and secondary immune responses in the rat spleen. Am. J. Anat. 121, 305-317 (1967).
121. Clark, J. M. & Weiss, L. Effects of a bacterial vaccine on the marginal zone of the spleen. Am. J. Anat. 132, 79-92 (1971).
122. Kumararatne, D. S., Bazin, H. & MacLennan, I. C. Marginal zones: the major B-cell compartment of rat spleens. Eur. J. Immunol. 11, 858-864 (1981).
123. Kumararatne, D. S. & MacLennan, I. C. Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur. J. Immunol. 11, 865-869 (1981).
124. Kumararatne, D. S., MacLennan, I. C., Bazin, H. & Gray, D. Marginal zones: the largest B-cell compartment of the rat spleen. Adv. Exp. Med. Biol. 149, 67-73 (1982).
125. Gray, D., Kumararatne, D. S., Lortan, J., Khan, M. & MacLennan, I. C. Relation of intra-splenic migration of marginal-zone B cells to antigen localization on follicular dendritic cells. Immunology 52, 659-669 (1984).
126. Humphrey, J. H. Splenic macrophages: antigen-presenting cells for T1-2 antigens. Immunol. Lett. 11, 149-152 (1985).
127. Kraal, G. & Janse, M. Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 58, 665-669 (1986).
128. Dijkstra, C. D., Van, V. E., Dopp, E. A., van der Lelij, A. A. & Kraal, G. Marginal-zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities. Immunology 55, 23-30 (1985).
129. Balazs, M., Horvath, G., Grama, L. & Balogh, P. Phenotypic identification and development of distinct microvascular compartments in the postnatal mouse spleen. Cell. Immunol. 212, 126-137 (2001).
130. Liu, Y. J., Zhang, J., Lane, P. J., Chan, E. Y. & MacLennan, I. C. Sites of specific B-cell activation in primary and secondary responses to T-cell-dependent and T-cell-independent antigens. Eur. J. Immunol. 21, 2951-2962 (1991).
131. Dunn-Walters, D. K., Isaacson, P. G. & Spencer, J. Analysis of mutations in immunoglobulin heavy-chain variable-region genes of microdissected marginal-zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. Br. Exp. Med. 182, 559-566 (1995).
132. Spencer, J., Perry, M. E. & Dunn-Walters, D. K. Human marginal-zone B cells. Immunol. Today 19, 421-426 (1998).